Life Technologies Posts 3 Percent Revenue Gain in Q4, Provides Few Details on Strategic Review | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market Monday that its fourth-quarter revenues rose 3 percent on a non-GAAP basis but were down 1 percent on a GAAP basis.

The Carlsbad, Calif.-based genetic analysis tools firm reported total revenues of $998.9 million for the three months ended Dec. 31, compared to $1.01 billion for the fourth quarter of 2011. However, on a non-GAAP basis, its revenues were up 3 percent to $999.4 million from $970.3 million. Excluding the effects of currency translation its revenues were up 4.5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.